215 related articles for article (PubMed ID: 37544025)
1. Telmisartan inhibits microglia-induced neurotoxic A1 astrocyte conversion via PPARγ-mediated NF-κB/p65 degradation.
Quan W; Xu CS; Li XC; Yang C; Lan T; Wang MY; Yu DH; Tang F; Wang ZF; Li ZQ
Int Immunopharmacol; 2023 Oct; 123():110761. PubMed ID: 37544025
[TBL] [Abstract][Full Text] [Related]
2. Telmisartan ameliorates Aβ oligomer-induced inflammation via PPARγ/PTEN pathway in BV2 microglial cells.
Wang ZF; Li J; Ma C; Huang C; Li ZQ
Biochem Pharmacol; 2020 Jan; 171():113674. PubMed ID: 31634455
[TBL] [Abstract][Full Text] [Related]
3. Telmisartan Protects a Microglia Cell Line from LPS Injury Beyond AT1 Receptor Blockade or PPARγ Activation.
Elkahloun AG; Rodriguez Y; Alaiyed S; Wenzel E; Saavedra JM
Mol Neurobiol; 2019 May; 56(5):3193-3210. PubMed ID: 30105672
[TBL] [Abstract][Full Text] [Related]
4. Telmisartan inhibits cytokine-induced nuclear factor-kappaB activation independently of the peroxisome proliferator-activated receptor-gamma.
Nakano A; Hattori Y; Aoki C; Jojima T; Kasai K
Hypertens Res; 2009 Sep; 32(9):765-9. PubMed ID: 19590508
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor necrosis factor-alpha-induced interleukin-6 expression by telmisartan through cross-talk of peroxisome proliferator-activated receptor-gamma with nuclear factor kappaB and CCAAT/enhancer-binding protein-beta.
Tian Q; Miyazaki R; Ichiki T; Imayama I; Inanaga K; Ohtsubo H; Yano K; Takeda K; Sunagawa K
Hypertension; 2009 May; 53(5):798-804. PubMed ID: 19289654
[TBL] [Abstract][Full Text] [Related]
6. Candesartan modulates microglia activation and polarization via NF-κB signaling pathway.
Qie S; Ran Y; Lu X; Su W; Li W; Xi J; Gong W; Liu Z
Int J Immunopathol Pharmacol; 2020; 34():2058738420974900. PubMed ID: 33237822
[TBL] [Abstract][Full Text] [Related]
7. Protective mechanisms of telmisartan against hepatic ischemia/reperfusion injury in rats may involve PPARγ-induced TLR4/NF-κB suppression.
Morsy MA; Abdel-Gaber SA; Rifaai RA; Mohammed MM; Nair AB; Abdelzaher WY
Biomed Pharmacother; 2022 Jan; 145():112374. PubMed ID: 34915671
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.
Imayama I; Ichiki T; Inanaga K; Ohtsubo H; Fukuyama K; Ono H; Hashiguchi Y; Sunagawa K
Cardiovasc Res; 2006 Oct; 72(1):184-90. PubMed ID: 16938288
[TBL] [Abstract][Full Text] [Related]
9. Telmisartan attenuates hyperglycemia-exacerbated VCAM-1 expression and monocytes adhesion in TNFα-stimulated endothelial cells by inhibiting IKKβ expression.
Song KH; Park JH; Jo I; Park JY; Seo J; Kim SA; Cho DH
Vascul Pharmacol; 2016 Mar; 78():43-52. PubMed ID: 26455386
[TBL] [Abstract][Full Text] [Related]
10. Modulatory effect of IL-1 inhibition following lipopolysaccharide-induced neuroinflammation in neonatal microglia and astrocytes.
Pierre WC; Londono I; Quiniou C; Chemtob S; Lodygensky GA
Int J Dev Neurosci; 2022 May; 82(3):243-260. PubMed ID: 35315121
[TBL] [Abstract][Full Text] [Related]
11. TLR4/MyD88/NF-κB signaling and PPAR-γ within the paraventricular nucleus are involved in the effects of telmisartan in hypertension.
Li HB; Li X; Huo CJ; Su Q; Guo J; Yuan ZY; Zhu GQ; Shi XL; Liu JJ; Kang YM
Toxicol Appl Pharmacol; 2016 Aug; 305():93-102. PubMed ID: 27292124
[TBL] [Abstract][Full Text] [Related]
12. Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-γ activation in human monocytes.
Pang T; Benicky J; Wang J; Orecna M; Sanchez-Lemus E; Saavedra JM
J Hypertens; 2012 Jan; 30(1):87-96. PubMed ID: 22124178
[TBL] [Abstract][Full Text] [Related]
13. Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease.
Garrido-Gil P; Joglar B; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
J Neuroinflammation; 2012 Feb; 9():38. PubMed ID: 22356806
[TBL] [Abstract][Full Text] [Related]
14. Telmisartan inhibits CD4-positive lymphocyte migration independent of the angiotensin type 1 receptor via peroxisome proliferator-activated receptor-gamma.
Walcher D; Hess K; Heinz P; Petscher K; Vasic D; Kintscher U; Clemenz M; Hartge M; Raps K; Hombach V; Marx N
Hypertension; 2008 Feb; 51(2):259-66. PubMed ID: 18158351
[TBL] [Abstract][Full Text] [Related]
15. MFG-E8 reverses microglial-induced neurotoxic astrocyte (A1) via NF-κB and PI3K-Akt pathways.
Xu X; Zhang A; Zhu Y; He W; Di W; Fang Y; Shi X
J Cell Physiol; 2018 Jan; 234(1):904-914. PubMed ID: 30076715
[TBL] [Abstract][Full Text] [Related]
16. Telmisartan, an angiotensin II receptor blocker, attenuates Prevotella intermedia lipopolysaccharide-induced production of nitric oxide and interleukin-1β in murine macrophages.
Choe SH; Choi EY; Hyeon JY; Keum BR; Choi IS; Kim SJ
Int Immunopharmacol; 2019 Oct; 75():105750. PubMed ID: 31330445
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory factors and amyloid β-induced microglial polarization promote inflammatory crosstalk with astrocytes.
Xie L; Zhang N; Zhang Q; Li C; Sandhu AF; Iii GW; Lin S; Lv P; Liu Y; Wu Q; Yu S
Aging (Albany NY); 2020 Nov; 12(22):22538-22549. PubMed ID: 33196457
[TBL] [Abstract][Full Text] [Related]
18. Effect of telmisartan on nitric oxide--asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxisome proliferator activated receptor gamma signaling during endothelial aging.
Scalera F; Martens-Lobenhoffer J; Bukowska A; Lendeckel U; Täger M; Bode-Böger SM
Hypertension; 2008 Mar; 51(3):696-703. PubMed ID: 18250362
[TBL] [Abstract][Full Text] [Related]
19. Blocking Two-Pore Domain Potassium Channel TREK-1 Inhibits the Activation of A1-Like Reactive Astrocyte Through the NF-κB Signaling Pathway in a Rat Model of Major Depressive Disorder.
Cong T; Sun Y; Zhou Y; Wu H; Li L; Chu Z; Chen X; Li J; Zhao D; Wang Y; Liu Y; Yin S; Xiao Z
Neurochem Res; 2023 Jun; 48(6):1737-1754. PubMed ID: 36670238
[TBL] [Abstract][Full Text] [Related]
20. Serelaxin Inhibits Lipopolysaccharide-induced Inflammatory Response in Cardiac Fibroblasts by Activating Peroxisome Proliferator-activated Receptor-γ and Suppressing the Nuclear Factor-Kappa B Signaling Pathway.
Wu X; Lv Y; Li Z; Yang Z
J Cardiovasc Pharmacol; 2023 Sep; 82(3):201-211. PubMed ID: 37418294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
